PATENTED: ERALYTICS FILLINGPROOF™ TECHNOLOGY
December 19, 2022
We are excited to inform you that eralytics has been granted the patent US 11,493,417 B2 for the automated bubble detection and bubble quantification technology FillingProofTM . When measuring a liquid’s density, the U-tube’s vertical orientation minimizes the likelihood of air bubbles becoming trapped in the density cell. To ensure bubble-free filling, eralytics has developed Filling ProofTM. This technology is [...]
December 19, 2022
We are glad to announce that Celtarys Research has reached a strategic research cooperation agreement with the European platform EU-OPENSCREEN (https://www.eu-openscreen.eu ), a not-for-profit European Research Infrastructure Consortium (ERIC) for chemical biology and early drug discovery, supporting all stages of a chemical tool development including assay adaptation, high-throughput screening, and chemical optimisation of the ‘hit’ compounds. [...]
December 19, 2022
Shimadzu Corporation (Shimadzu) has now entered into a two-year research agreement with and the Earle A. Chiles Research Institute, a division of Providence Cancer Institute (Providence) in Portland, Oregon, Japanese Foundation for Cancer Research (JFCR) in Ariake, Tokyo, one of the advanced cancer treatment hospitals and research institutions in Japan. Shimadzu and Providence have been [...]
FonesLife offers the 7,000-plex SomaScan® Platform as Japan’s first SomaLogic™ Certified Site
December 19, 2022
TOKYO and BOULDER, Colo. -- SomaLogic, Inc., a leader in proteomic technology, announced today that Tokyo-based FonesLife Corporation, will be the first SomaLogic™ Certified Site in Japan. The new site will offer the 7,000-plex SomaScan® Assay in their labs and provide SomaScan data to their customers. By becoming a SomaLogic Certified Site, FonesLife can now run [...]
CN Bio appoints Dr Paul Brooks as Chief Executive Officer
December 19, 2022
Key strategic appointment as the Company enters next phase of commercial growth and global expansion of its products and services.Former CEO, Dr David Hughes, appointed to Scientific Advisory Board. CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the appointment of Dr Paul Brooks, formerly the [...]
December 19, 2022
Shimadzu Corporation (Shimadzu) has now entered into a two-year research agreement with and the Earle A. Chiles Research Institute, a division of Providence Cancer Institute (Providence) in Portland, Oregon, Japanese Foundation for Cancer Research (JFCR) in Ariake, Tokyo, one of the advanced cancer treatment hospitals and research institutions in Japan. Shimadzu and Providence have been [...]
Timegate is Launching a Service Business
December 16, 2022
Timegate Instruments is launching a Service Business and offering sample measurements for our customers. We want to study the feasibility of our Timegated® Raman technology and have also noticed a great demand for such a service. Order sample measurements easily by using our website ordering platform: Timegated Raman measurements. "This development is great for Timegate. With the service business launch, [...]
December 16, 2022
Hadfield, UK – UK genomics company, RevoluGen Ltd. is pleased to announce it has entered into a non-exclusive distribution agreement with BioEntist of Thailand for the distribution of its Fire Monkey™ High Molecular Weight (HMW)-DNA extraction product range. Under the terms of the agreement, RevoluGen has granted BioEntist the rights to promote, market and sell [...]
December 15, 2022
SAN DIEGO -- Scale Biosciences, Inc. (ScaleBio), a pioneer in single-cell sequencing and combinatorial indexing technologies, has transitioned from research and development to commercial stage with the release of its first generation single-cell transcriptomics scRNAseq profiling and analysis solution, establishing new standards for accessible, scalable, and low-cost single-cell sequencing. ScaleBio’s scRNAseq solution, built upon the [...]
Fast, Cost-Effective Products for Extracellular Vesicle Isolation
December 15, 2022
AMSBIO announce a new range of different isolation products for fast, scalable, and reproducible purification of Extracellular Vesicles (EV), including exosomes, as well as addressing EV heterogeneity and high throughput solutions for biomarker discovery. Traditionally ultracentrifugation has been the favored method for EV isolation or separation. Though it is still widely used, ultracentrifugation not only tends [...]

